STOCK TITAN

[8-K] US Physical Therapy Inc Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Gevo, Inc. (GEVO) – Form 144 filing

An insider intends to sell up to 11,694 common shares through broker Stifel Nicolaus on or about 1 Aug 2025. The stock block is valued at $14,992, implying an estimated price of roughly $1.28 per share. With 239.56 million shares outstanding, the proposed sale equates to less than 0.005 % of total float, signalling negligible dilution risk.

The filer received 22,962 shares on 26 Jul 2025 via restricted-stock units and has already disposed of 23,994 shares for $30,760 during the past three months. By signing, the seller affirms no possession of undisclosed adverse information. The filing is a notice only; it neither guarantees execution nor conveys new fundamental data about Gevo’s operations.

While routine, repeated insider sales can influence sentiment, the size and value of this transaction are immaterial to the company’s capital structure.

Gevo, Inc. (GEVO) – Deposito Modulo 144

Un insider intende vendere fino a 11.694 azioni ordinarie tramite il broker Stifel Nicolaus intorno al 1° agosto 2025. Il blocco azionario ha un valore di 14.992 dollari, con un prezzo stimato di circa 1,28 dollari per azione. Con 239,56 milioni di azioni in circolazione, la vendita proposta rappresenta meno dello 0,005% del flottante totale, indicando un rischio di diluizione trascurabile.

Il dichiarante ha ricevuto 22.962 azioni il 26 luglio 2025 tramite unità di azioni vincolate e ha già venduto 23.994 azioni per 30.760 dollari negli ultimi tre mesi. Firmando, il venditore conferma di non possedere informazioni negative non divulgate. Il deposito è solo una notifica; non garantisce l'esecuzione né fornisce nuovi dati fondamentali sulle operazioni di Gevo.

Pur essendo una procedura di routine, vendite ripetute da parte di insider possono influenzare il sentiment, ma la dimensione e il valore di questa transazione sono irrilevanti per la struttura del capitale dell’azienda.

Gevo, Inc. (GEVO) – Presentación del Formulario 144

Un insider tiene la intención de vender hasta 11.694 acciones ordinarias a través del corredor Stifel Nicolaus alrededor del 1 de agosto de 2025. El bloque de acciones está valorado en 14.992 dólares, lo que implica un precio estimado de aproximadamente 1,28 dólares por acción. Con 239,56 millones de acciones en circulación, la venta propuesta representa menos del 0,005% del flotante total, señalando un riesgo de dilución insignificante.

El declarante recibió 22.962 acciones el 26 de julio de 2025 mediante unidades restringidas de acciones y ya ha vendido 23.994 acciones por 30.760 dólares en los últimos tres meses. Al firmar, el vendedor afirma no poseer información adversa no divulgada. La presentación es solo una notificación; no garantiza la ejecución ni aporta nuevos datos fundamentales sobre las operaciones de Gevo.

Aunque es un trámite rutinario, las ventas repetidas de insiders pueden influir en el sentimiento, pero el tamaño y valor de esta transacción son insignificantes para la estructura de capital de la compañía.

Gevo, Inc. (GEVO) – Form 144 제출

내부자가 2025년 8월 1일경 중개인 Stifel Nicolaus를 통해 최대 11,694주의 보통주를 매도할 계획입니다. 해당 주식 블록의 가치는 14,992달러로, 주당 약 1.28달러로 추정됩니다. 총 2억 3,956만 주가 발행된 상태에서 이번 매도는 총 유통 주식의 0.005% 미만에 해당하여 희석 위험이 거의 없음을 나타냅니다.

신고자는 2025년 7월 26일 제한 주식 단위(RSU)로 22,962주를 받았으며, 지난 3개월 동안 23,994주를 30,760달러에 이미 처분했습니다. 서명함으로써 매도자는 미공개 불리한 정보를 보유하지 않았음을 확인합니다. 이번 제출은 단순 통지일 뿐, 거래 실행을 보장하지 않으며 Gevo의 운영에 관한 새로운 기본 정보를 제공하지 않습니다.

일상적인 절차이지만 반복적인 내부자 매도는 투자 심리에 영향을 줄 수 있으나, 이번 거래의 규모와 가치는 회사의 자본 구조에 미미한 영향을 미칩니다.

Gevo, Inc. (GEVO) – Dépôt du formulaire 144

Un initié prévoit de vendre jusqu'à 11 694 actions ordinaires via le courtier Stifel Nicolaus aux alentours du 1er août 2025. Le bloc d'actions est évalué à 14 992 dollars, ce qui implique un prix estimé d'environ 1,28 dollar par action. Avec 239,56 millions d'actions en circulation, la vente proposée représente moins de 0,005 % du flottant total, indiquant un risque de dilution négligeable.

Le déclarant a reçu 22 962 actions le 26 juillet 2025 par le biais d'unités d'actions restreintes et a déjà vendu 23 994 actions pour 30 760 dollars au cours des trois derniers mois. En signant, le vendeur affirme ne pas détenir d'informations défavorables non divulguées. Le dépôt est une simple notification ; il ne garantit pas l'exécution ni n'apporte de nouvelles données fondamentales sur les opérations de Gevo.

Bien que routinières, des ventes répétées d'initiés peuvent influencer le sentiment, mais la taille et la valeur de cette transaction sont insignifiantes pour la structure du capital de l'entreprise.

Gevo, Inc. (GEVO) – Form 144 Einreichung

Ein Insider beabsichtigt, bis zu 11.694 Stammaktien über den Broker Stifel Nicolaus etwa am 1. August 2025 zu verkaufen. Der Aktienblock hat einen Wert von 14.992 US-Dollar, was auf einen geschätzten Preis von etwa 1,28 US-Dollar pro Aktie hindeutet. Bei 239,56 Millionen ausstehenden Aktien entspricht der geplante Verkauf weniger als 0,005 % des Gesamtbestands und signalisiert somit ein vernachlässigbares Verwässerungsrisiko.

Der Einreicher erhielt am 26. Juli 2025 22.962 Aktien durch Restricted Stock Units und hat in den letzten drei Monaten bereits 23.994 Aktien für 30.760 US-Dollar veräußert. Mit seiner Unterschrift bestätigt der Verkäufer, keine nicht offengelegten negativen Informationen zu besitzen. Die Einreichung ist lediglich eine Mitteilung; sie garantiert weder die Ausführung noch liefert sie neue fundamentale Informationen über die Geschäftstätigkeit von Gevo.

Obwohl routinemäßig, können wiederholte Insiderverkäufe die Stimmung beeinflussen, doch sind Umfang und Wert dieser Transaktion für die Kapitalstruktur des Unternehmens unerheblich.

Positive
  • None.
Negative
  • Continued insider selling within a short window may weigh on market sentiment, even though the dollar amount is small.

Insights

TL;DR: Small Form 144 sale; negligible dilution; sentiment impact limited.

The proposed 11.7 K-share sale equals <0.005 % of GEVO’s float and only ~$15 K in value. Such a minor block will not affect liquidity or valuation metrics. Form 144s are permissive, not mandatory; actual execution may differ. Investors should monitor patterns—this filer sold 24 K shares in May—but the scale remains immaterial. I view the disclosure as neutral to the investment thesis.

TL;DR: Insider selling persists, mildly negative for perception.

Although quantitatively insignificant, back-to-back sales within three months suggest continuing liquidity harvesting by the insider. Market participants often interpret cumulative insider selling as a soft signal of limited near-term upside. However, absence of undisclosed negative information is affirmed, and the sale does not breach governance norms. Overall impact is slightly negative but not material.

Gevo, Inc. (GEVO) – Deposito Modulo 144

Un insider intende vendere fino a 11.694 azioni ordinarie tramite il broker Stifel Nicolaus intorno al 1° agosto 2025. Il blocco azionario ha un valore di 14.992 dollari, con un prezzo stimato di circa 1,28 dollari per azione. Con 239,56 milioni di azioni in circolazione, la vendita proposta rappresenta meno dello 0,005% del flottante totale, indicando un rischio di diluizione trascurabile.

Il dichiarante ha ricevuto 22.962 azioni il 26 luglio 2025 tramite unità di azioni vincolate e ha già venduto 23.994 azioni per 30.760 dollari negli ultimi tre mesi. Firmando, il venditore conferma di non possedere informazioni negative non divulgate. Il deposito è solo una notifica; non garantisce l'esecuzione né fornisce nuovi dati fondamentali sulle operazioni di Gevo.

Pur essendo una procedura di routine, vendite ripetute da parte di insider possono influenzare il sentiment, ma la dimensione e il valore di questa transazione sono irrilevanti per la struttura del capitale dell’azienda.

Gevo, Inc. (GEVO) – Presentación del Formulario 144

Un insider tiene la intención de vender hasta 11.694 acciones ordinarias a través del corredor Stifel Nicolaus alrededor del 1 de agosto de 2025. El bloque de acciones está valorado en 14.992 dólares, lo que implica un precio estimado de aproximadamente 1,28 dólares por acción. Con 239,56 millones de acciones en circulación, la venta propuesta representa menos del 0,005% del flotante total, señalando un riesgo de dilución insignificante.

El declarante recibió 22.962 acciones el 26 de julio de 2025 mediante unidades restringidas de acciones y ya ha vendido 23.994 acciones por 30.760 dólares en los últimos tres meses. Al firmar, el vendedor afirma no poseer información adversa no divulgada. La presentación es solo una notificación; no garantiza la ejecución ni aporta nuevos datos fundamentales sobre las operaciones de Gevo.

Aunque es un trámite rutinario, las ventas repetidas de insiders pueden influir en el sentimiento, pero el tamaño y valor de esta transacción son insignificantes para la estructura de capital de la compañía.

Gevo, Inc. (GEVO) – Form 144 제출

내부자가 2025년 8월 1일경 중개인 Stifel Nicolaus를 통해 최대 11,694주의 보통주를 매도할 계획입니다. 해당 주식 블록의 가치는 14,992달러로, 주당 약 1.28달러로 추정됩니다. 총 2억 3,956만 주가 발행된 상태에서 이번 매도는 총 유통 주식의 0.005% 미만에 해당하여 희석 위험이 거의 없음을 나타냅니다.

신고자는 2025년 7월 26일 제한 주식 단위(RSU)로 22,962주를 받았으며, 지난 3개월 동안 23,994주를 30,760달러에 이미 처분했습니다. 서명함으로써 매도자는 미공개 불리한 정보를 보유하지 않았음을 확인합니다. 이번 제출은 단순 통지일 뿐, 거래 실행을 보장하지 않으며 Gevo의 운영에 관한 새로운 기본 정보를 제공하지 않습니다.

일상적인 절차이지만 반복적인 내부자 매도는 투자 심리에 영향을 줄 수 있으나, 이번 거래의 규모와 가치는 회사의 자본 구조에 미미한 영향을 미칩니다.

Gevo, Inc. (GEVO) – Dépôt du formulaire 144

Un initié prévoit de vendre jusqu'à 11 694 actions ordinaires via le courtier Stifel Nicolaus aux alentours du 1er août 2025. Le bloc d'actions est évalué à 14 992 dollars, ce qui implique un prix estimé d'environ 1,28 dollar par action. Avec 239,56 millions d'actions en circulation, la vente proposée représente moins de 0,005 % du flottant total, indiquant un risque de dilution négligeable.

Le déclarant a reçu 22 962 actions le 26 juillet 2025 par le biais d'unités d'actions restreintes et a déjà vendu 23 994 actions pour 30 760 dollars au cours des trois derniers mois. En signant, le vendeur affirme ne pas détenir d'informations défavorables non divulguées. Le dépôt est une simple notification ; il ne garantit pas l'exécution ni n'apporte de nouvelles données fondamentales sur les opérations de Gevo.

Bien que routinières, des ventes répétées d'initiés peuvent influencer le sentiment, mais la taille et la valeur de cette transaction sont insignifiantes pour la structure du capital de l'entreprise.

Gevo, Inc. (GEVO) – Form 144 Einreichung

Ein Insider beabsichtigt, bis zu 11.694 Stammaktien über den Broker Stifel Nicolaus etwa am 1. August 2025 zu verkaufen. Der Aktienblock hat einen Wert von 14.992 US-Dollar, was auf einen geschätzten Preis von etwa 1,28 US-Dollar pro Aktie hindeutet. Bei 239,56 Millionen ausstehenden Aktien entspricht der geplante Verkauf weniger als 0,005 % des Gesamtbestands und signalisiert somit ein vernachlässigbares Verwässerungsrisiko.

Der Einreicher erhielt am 26. Juli 2025 22.962 Aktien durch Restricted Stock Units und hat in den letzten drei Monaten bereits 23.994 Aktien für 30.760 US-Dollar veräußert. Mit seiner Unterschrift bestätigt der Verkäufer, keine nicht offengelegten negativen Informationen zu besitzen. Die Einreichung ist lediglich eine Mitteilung; sie garantiert weder die Ausführung noch liefert sie neue fundamentale Informationen über die Geschäftstätigkeit von Gevo.

Obwohl routinemäßig, können wiederholte Insiderverkäufe die Stimmung beeinflussen, doch sind Umfang und Wert dieser Transaktion für die Kapitalstruktur des Unternehmens unerheblich.



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549


FORM 8-K


 CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 1, 2025


 U.S. PHYSICAL THERAPY, INC.
(Exact name of registrant as specified in its charter)


Nevada

 
001-11151

 
76-0364866

(State or other jurisdiction
of incorporation or organization)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)

1300 WEST SAM HOUSTON PARKWAY,
SUITE 300, HOUSTON, Texas
 
77043

(Address of Principal Executive Offices)
 
(Zip Code)

Registrant's telephone number, including area code: (713) 297-7000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   

Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
   

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 par value

USPH

New York Stock Exchange


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 
Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


ITEM 8.01 Other Event.
 
On August 1, 2025  – U.S. Physical Therapy, Inc. (the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy practice with three clinic locations, which currently generates approximately $5.3 million in annual revenues and 28,000 in annual visits.  The Company acquired a 60% interest in the practice with the current owners retaining a 40% ownership interest.
A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Current Report on Form 8-K, including the exhibits, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


ITEM 9.01   FINANCIAL STATEMENTS AND EXHIBITS

     
Exhibits
 
Description of Exhibits
   
99.1
 
 Registrant's Press Release dated August 1, 2025

 
 

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

               
       
U.S. PHYSICAL THERAPY, INC.
 
         
Dated: August 1, 2025
     
By:
 
/s/ CAREY HENDRICKSON
 
           
Carey Hendrickson
 
           
Chief Financial Officer
 
           
(duly authorized officer and principal financial and accounting officer)
 



FAQ

How many GEVO shares are being registered for sale in this Form 144?

The filing covers 11,694 common shares.

What is the approximate value of the planned insider sale?

The aggregate market value is listed as $14,992.

When can the GEVO shares be sold?

The insider indicated an approximate sale date of 01 Aug 2025.

What percentage of GEVO’s outstanding shares does this represent?

The block equals less than 0.005 % of the 239.56 million shares outstanding.

Has the insider sold GEVO shares recently?

Yes, 23,994 shares were sold on 30 May 2025 for $30,760 in gross proceeds.

Does the Form 144 guarantee the sale will occur?

No. Form 144 is a notice of intent; the insider may decide not to execute the sale.
U S Physical Therapy

NYSE:USPH

USPH Rankings

USPH Latest News

USPH Latest SEC Filings

USPH Stock Data

1.14B
14.88M
1.94%
105.51%
3.57%
Medical Care Facilities
Services-health Services
Link
United States
HOUSTON